Skip to content

10x Genomics, Inc. TXG Asset turnover

Asset turnover at other companies

TEC
Bio-TechneTECH
0.5×0.0×
Bruker logo
BrukerBRKR
0.6×-0.1×
Illumina logo
IlluminaILMN
0.7×+0.2×
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
0.6×+0.1×
Revvity logo
RevvityRVTY
0.2×0.0×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
0.3×0.0×

Other financials

Income statement

See full
Revenue$150.8M-2.6%
Gross profit$106.2M+0.7%
Operating income-$17.0M+56.7%
Net income-$13.5M+60.8%
EPS (diluted)-$0.10+64.3%

Balance sheet

See full
Cash & equivalents$490.3M+30.0%
Total debt$81.4M+1.6%
Total equity$814.3M+15.2%
Total assets$1.0B+12.4%

Cash flow

See full
Operating cash flow$26.1M-24.0%
CapEx$1.6M-15.6%
Free cash flow$24.5M-24.4%

Valuation

See full
Market cap$4.41B+154%
Enterprise value$4B+199%
P/S6.9×+4.1×

Profitability

See full
Gross margin69.6%+1.2pp
Operating margin-6.1%-2.7pp
Net margin-3.5%-1.6pp
FCF margin19.1%

Returns & leverage

See full
Return on equity-3%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.9×+0.5×

Where this comes from

Calculated from 10x Genomics, Inc.’s reported figures.

Based on trailing twelve months.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 10x Genomics, Inc.'s asset turnover?
10x Genomics, Inc. (TXG) reported asset turnover of 0.7× in Q1 2026.
How has 10x Genomics, Inc.'s asset turnover changed year-over-year?
10x Genomics, Inc.'s asset turnover decreased by 2.7% year-over-year, from 0.7× to 0.7×.
What is the long-term trend for 10x Genomics, Inc.'s asset turnover?
Over 5 years (2020 to 2025), 10x Genomics, Inc.'s asset turnover has grown at a 11.0% compound annual growth rate (CAGR), from 0.4× to 0.7×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.